Search
Search Results
-
Association between thymic hyperplasia and serum calcium level in Graves’ disease
BackgroundGraves' disease increases bone resorption in hyperthyroidism, leading to elevated serum calcium levels and a negative bone balance. Thymic...
-
Graves’ disease thyroid dermopathy: a case report
BackgroundGraves’ disease is the autoimmune activation of the thyroid gland causing diffuse enlargement and hyperfunction of the gland....
-
Causality of blood metabolites and metabolic pathways on Graves’ disease and Graves’ ophthalmopathy: a two-sample Mendelian randomization study
ObjectivesThere is ample that metabolic dysregulation is involved in Graves’ disease (GD) and Graves’ ophthalmopathy (GO). Recent studies have...
-
The genetics of Graves’ disease
Graves’ disease (GD) is the commonest cause of hyperthyroidism and has a strong female preponderance. Everyday clinical practice suggests strong...
-
Sex-specific risk factors associated with graves’ orbitopathy in Korean patients with newly diagnosed graves’ disease
ObjectiveTo assess sex-specific risk factors for Graves’ orbitopathy (GO) in newly diagnosed Graves’ disease (GD) patients.
MethodsA retrospective...
-
Characterization, treatment preferences, and outcomes of 390 Egyptian Graves’ disease patients: a retrospective study
BackgroundGraves’ disease is the most common cause of thyrotoxicosis worldwide. Patient characteristics may vary according to ethnicity, iodine...
-
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
ObjectiveA relationship between thyroid and non-organ-specific autoimmunity could be relevant for Graves’ orbitopathy (GO), which affects connective...
-
Silent subepicardial hematoma due to spontaneous coronary artery rupture in a patient with Graves’ disease
BackgroundSubepicardial hematoma due to spontaneous coronary artery rupture (SCAR) is exceedingly rare.
Case presentationAn asymptomatic 68-year-old...
-
TSH receptor antibody as a predictor of difficult robotic thyroidectomy in patients with Graves’ disease
Thyroidectomy in Graves’ disease can be challenging due to greater thyroid size and vascularity. While thyroid stimulating hormone receptor antibody...
-
Graves’ disease-induced immune thrombocytopenic purpura in an African female: a case report
BackgroundImmune thrombocytopenic purpura is a condition associated with an unusual, unexplained, and sometimes very severe reduction in the level of...
-
2021 Asia-Pacific Graves’ Disease Consortium Survey of Clinical Practice Patterns in the Management of Graves’ Disease
AimAlthough Graves’ disease (GD) is common in endocrine practices worldwide, global differences in diagnosis and management remain. We sought to...
-
Endothelial dysfunction in children with newly diagnosed Graves’ disease
The most frequent cause of hyperthyroidism in children is Graves’ disease (GD). Vascular endothelium is a specific target of thyroid hormone. The...
-
Graves disease is associated with increased risk of clinical Alzheimer’s disease: evidence from the Medicare system
BackgroundIdentification of modifiable risk factors for Alzheimer’s Disease (AD) onset is an important aspect of controlling the burden imposed by...
-
Surgical outcome after thyroidectomy due to Graves’ disease and Lugol iodine treatment: a retrospective register-based cohort study
PurposeThis study aimed to investigate the relationship between Lugol iodine treatment in a rescue setting and surgical outcomes in Graves’ disease...
-
Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves’ disease
PurposeThe aim is to validate the third generation Thyrotropin receptor antibody (TRAb) assay for predicting neonatal thyroid dysfunction and adverse...
-
Familial dysalbuminemic hyperthyroxinemia combined with Graves’ disease: a rare case report
BackgroundFamilial dysalbuminemic hyperthyroxinemia (FDH) is an autosomal dominant disease characterised by an abnormally increased affinity of...
-
V600E BRAF-mutated anaplastic thyroid carcinoma after radioactive iodine for Graves’ disease: a case report and a review of the literature
IntroductionRadioactive iodine (RAI) therapy is part of the treatment option for Graves’ disease, and it is widely accepted to be safe. However, some...
-
A prospective cross-sectional study on hypocalcemia after total thyroidectomy in patients with Graves’ disease: insights on secondary hyperparathyroidism
PurposeTo investigate the parathyroid function and calcium (Ca) levels in the secondary hyperparathyroidism (SHPT) state in patients with Graves’...
-
Graves’ disease after exposure to the SARS-CoV-2 vaccine: a case report and review of the literature
BackgroundAutoimmune/inflammatory syndrome induced by adjuvants (ASIA) is characterized by immune system dysregulation after exposure to adjuvants,...
-
Prospective study to evaluate radioactive iodine of 20 mCi vs 10–15 mCi in Graves’ disease
ObjectivesTo assess whether increasing radioactive iodine dose can increase treatment efficacy in Graves’ disease.
MethodsA prospective study was...
